A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is
@ERSpublications Early detection and accurate management of comorbidity have benefits in reducing ILD morbidity and mortality ABSTRACT Fibrosing lung disorders include a large number of diseases with diverse behaviour. Patients can die because of the progression of their illness, remain stable or even improve after appropriate treatment has been instituted. Comorbidities, such as acute and chronic infection, gastro-oesophageal reflux, pulmonary hypertension, lung cancer, cardiovasculardoi:10.1183/16000617.0027-2016 pmid:28049126 fatcat:hjrhoiesqvhf5e5gyh2k4myx6q